Last reviewed · How we verify

NCT05225948: ESCAPE-SVD

Effects of Remote Ischemic Conditioning on Dynamic Cerebral Autoregulation, Blood Pressure and Heart Rate Variability in Patients With Cerebral Small Vessel Disease

Status unknown NA Last updated 1 March 2024
What this trial tests

NA trial testing Remote ischemic conditioning in Cerebral Small Vessel Diseases in 100 participants. Status unknown.

Timeline
30 December 2021
Primary endpoint
1 July 2025
31 October 2025

Quick facts

Lead sponsorYi Yang
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment100
Start date30 December 2021
Primary completion1 July 2025
Estimated completion31 October 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Yi Yang — full company profile →

Who can join

Eligibility, any sex, with Cerebral Small Vessel Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine effects of remote ischemic conditioning on dynamic cerebral autoregulation, blood pressure and heart rate variability in patients with cerebral small vessel disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Remote ischemic conditioning

Trials testing the same drug.

Other recruiting trials for Cerebral Small Vessel Diseases

Currently open trials in the same condition.

Other Yi Yang trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05225948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing